Linhui Wang

2PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 27, 2026
Isocyanate-Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3-Mediated Extracellular Matrix Remodeling and cGAS-STING Pathway Activation in Bladder Cancer.

|Oct 28, 2021
Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.

Linhui Wang, Yutao Wang, Jianfeng Wang

Pageof 1

Frequent Collaborators

1 joint publications

Yutao Wang

1 joint publications

Jianfeng Wang

1 joint publications

Luanfeng Li

1 joint publications

Jianbin Bi